Vital Signs: Winter 2021 Magazine | Penn Medicine
Laying the Groundwork for COVID-19 Vaccines: Dr. Drew Weissman and mRNA Technology at Penn Medicine - YouTube
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | PLOS Pathogens
The Story Behind the mRNA COVID Vaccines | Dr. Drew Weissman and Dr. Katalin Kariko | Pfizer | COVID-19 mRNA vaccine pioneers Dr. Drew Weissman and Dr. Katalin Karikó have been awarded
A new herpes vaccine leaves no trace of infection or disease | Penn Today
After COVID-19 Successes, Researchers Push to Develop mRNA Vaccines for Other Diseases - Scientific American
From foundational discoveries to profound impact | Penn Today
How vaccines may affect the cornea - EyeWorld
University of Pennsylvania mRNA Biology Pioneers Receive COVID-19 Vaccine Enabled by their Foundational Research - Penn Medicine
Cureus | Hypertrophic Perianal Herpes Mimicking Squamous Cell Cancer: A Case Report and a Review of the Literature
Uptake of herpes zoster vaccine linked to supply | ACP Internist
Dr. Drew Weissman on the exciting future of mRNA | Christie's
World Immunization Week 2018 - Penn Medicine
JCI - Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | PLOS Pathogens
Researcher with Type 1 Diabetes Is Behind the COVID-19 Vaccines
mRNA Vaccines: A Bright Future in Vaccinology | Penn Medicine
COVID vaccine's mRNA technology also works for HIV vaccine - WHYY
Herpes vaccine is a winner in animals. Next up: Testing on humans.
Harvey M. Friedman | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania
Home | The Weissman Lab | Perelman School of Medicine at the University of Pennsylvania
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes | Science Immunology
Messenger RNA vaccines: Now proven against coronavirus, the technology can do so much more | CNN
Messenger RNA vaccines: Now proven against coronavirus, the technology can do so much more | CNN
New HSV-2 Vaccine Uses mRNA to Treat Herpes in Mice | Penn Medicine
Why 50+ People Should Get Vaccinated Against Shingles
Penn Medicine researchers develop vaccine for genital herpes | The Daily Pennsylvanian
